CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism.
暂无分享,去创建一个
[1] K. Kain,et al. Nonopsonic monocyte/macrophage phagocytosis of Plasmodium falciparum-parasitized erythrocytes: a role for CD36 in malarial clearance. , 2000, Blood.
[2] M. Lagueux,et al. Croquemort, a novel Drosophila hemocyte/macrophage receptor that recognizes apoptotic cells. , 1996, Immunity.
[3] James Scott,et al. Population genetics: Malaria susceptibility and CD36 mutation , 2000, Nature.
[4] T. Willson,et al. Interleukin-4-dependent production of PPAR-γ ligands in macrophages by 12/15-lipoxygenase , 1999, Nature.
[5] A. Bonen,et al. Muscle-specific Overexpression of FAT/CD36 Enhances Fatty Acid Oxidation by Contracting Muscle, Reduces Plasma Triglycerides and Fatty Acids, and Increases Plasma Glucose and Insulin* , 1999, The Journal of Biological Chemistry.
[6] R. Silverstein,et al. Identification of a CD36-related Thrombospondin 1–binding Domain in HIV-1 Envelope Glycoprotein gp120: Relationship to HIV-1–specific Inhibitory Factors in Human Saliva , 1998, The Journal of experimental medicine.
[7] Roy L. Silverstein,et al. CD36 and atherosclerosis , 2000, Current opinion in lipidology.
[8] C. Meldrum,et al. Biochemical isolation of a membrane microdomain from resting platelets highly enriched in the plasma membrane glycoprotein CD36. , 1996, The Biochemical journal.
[9] M. Krieger,et al. Scavenger receptor class B type I is a multiligand HDL receptor that influences diverse physiologic systems. , 2001, The Journal of clinical investigation.
[10] P. Grimaldi,et al. Cloning of a rat adipocyte membrane protein implicated in binding or transport of long-chain fatty acids that is induced during preadipocyte differentiation. Homology with human CD36. , 1993, The Journal of biological chemistry.
[11] R. F. Cook,et al. Characterization of caveolin-rich membrane domains isolated from an endothelial-rich source: implications for human disease , 1994, The Journal of cell biology.
[12] K. Nakajima,et al. Absent myocardial iodine-123-BMIPP uptake and platelet/monocyte CD36 deficiency. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[13] T. Sugihara,et al. Thrombospondin mediates adherence of CD36+ sickle reticulocytes to endothelial cells. , 1992, Blood.
[14] S. Gordon,et al. Is the class A macrophage scavenger receptor (SR-A) multifunctional? - The mouse's tale. , 2001, The Journal of clinical investigation.
[15] M. Krieger,et al. The other side of scavenger receptors: pattern recognition for host defense , 1997, Current opinion in lipidology.
[16] N. Hogg,et al. Macrophage vitronectin receptor, CD36, and thrombospondin cooperate in recognition of neutrophils undergoing programmed cell death. , 1991, Chest.
[17] M. Alessio,et al. CD36 is a ditopic glycoprotein with the N-terminal domain implicated in intracellular transport. , 2000, Biochemical and biophysical research communications.
[18] P. Grimaldi,et al. Regulation of FAT/CD36 gene expression: further evidence in support of a role of the protein in fatty acid binding/transport. , 1997, Prostaglandins, leukotrienes, and essential fatty acids.
[19] S. Ryeom,et al. CD36 participates in the phagocytosis of rod outer segments by retinal pigment epithelium. , 1996, Journal of cell science.
[20] K. Turley. The challenge of pulmonary hypertension. , 1991, Chest.
[21] R. Evans,et al. Oxidized LDL Regulates Macrophage Gene Expression through Ligand Activation of PPARγ , 1998, Cell.
[22] J. Barnwell,et al. Analysis of CD36 binding domains: ligand specificity controlled by dephosphorylation of an ectodomain. , 1993, Science.
[23] S. Hazen,et al. Macrophage scavenger receptor CD36 is the major receptor for LDL modified by monocyte-generated reactive nitrogen species. , 2000, The Journal of clinical investigation.
[24] James Scott,et al. Identification of Cd36 (Fat) as an insulin-resistance gene causing defective fatty acid and glucose metabolism in hypertensive rats , 1999, Nature Genetics.
[25] David W. Dawson,et al. CD36 Mediates the In Vitro Inhibitory Effects of Thrombospondin-1 on Endothelial Cells , 1997, The Journal of cell biology.
[26] Brian Seed,et al. CD36 directly mediates cytoadherence of Plasmodium falciparum parasitized erythrocytes , 1989, Cell.
[27] E. Dennis,et al. Monoclonal antibodies against oxidized low-density lipoprotein bind to apoptotic cells and inhibit their phagocytosis by elicited macrophages: evidence that oxidation-specific epitopes mediate macrophage recognition. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[28] Helen H. Hobbs,et al. Identification of Scavenger Receptor SR-BI as a High Density Lipoprotein Receptor , 1996, Science.
[29] R. Silverstein,et al. Histidine-rich glycoprotein inhibits the antiangiogenic effect of thrombospondin-1. , 2001, The Journal of clinical investigation.
[30] A. Gotto,et al. Induction of CD36 expression by oxidized LDL and IL-4 by a common signaling pathway dependent on protein kinase C and PPAR-gamma. , 2000, Journal of lipid research.
[31] R. Silverstein,et al. A Null Mutation in Murine CD36 Reveals an Important Role in Fatty Acid and Lipoprotein Metabolism* , 1999, The Journal of Biological Chemistry.
[32] Josephine C. Adams,et al. The Thrombospondin Gene Family , 1995 .
[33] D. Steinberg. Oxidative Modification of LDL and Atherogenesis , 1998 .
[34] E. Dennis,et al. Receptors for oxidized low-density lipoprotein on elicited mouse peritoneal macrophages can recognize both the modified lipid moieties and the modified protein moieties: implications with respect to macrophage recognition of apoptotic cells. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[35] R. Evans,et al. PPARγ Promotes Monocyte/Macrophage Differentiation and Uptake of Oxidized LDL , 1998, Cell.
[36] A. Rusiñol,et al. Isolation of a Somatic Cell Mutant Resistant to the Induction of Apoptosis by Oxidized Low Density Lipoprotein* , 2000, The Journal of Biological Chemistry.
[37] L. Stanton,et al. CD36 is a receptor for oxidized low density lipoprotein. , 1993, The Journal of biological chemistry.
[38] A. Gotto,et al. Transforming Growth Factor-β1 (TGF-β1) and TGF-β2 Decrease Expression of CD36, the Type B Scavenger Receptor, through Mitogen-activated Protein Kinase Phosphorylation of Peroxisome Proliferator-activated Receptor-γ* , 2000, The Journal of Biological Chemistry.
[39] M. Wilcox,et al. A Drosophila gene encoding an epithelial membrane protein with homology to CD36/LIMP II. , 1993, Journal of molecular biology.
[40] I. Yuhanna,et al. High Density Lipoprotein Prevents Oxidized Low Density Lipoprotein-induced Inhibition of Endothelial Nitric-oxide Synthase Localization and Activation in Caveolae* , 2000, The Journal of Biological Chemistry.
[41] M. L. Le Beau,et al. A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[42] Andrew C. Li,et al. Peroxisome proliferator–activated receptor γ ligands inhibit development of atherosclerosis in LDL receptor–deficient mice , 2000 .
[43] Y. Tomiyama,et al. A platelet membrane glycoprotein (GP) deficiency in healthy blood donors: Naka- platelets lack detectable GPIV (CD36) , 1990 .
[44] Loise M. Francisco,et al. Immature Dendritic Cells Phagocytose Apoptotic Cells via αvβ5 and CD36, and Cross-present Antigens to Cytotoxic T Lymphocytes , 1998, The Journal of experimental medicine.
[45] L. Yesner,et al. Regulated expression of CD36 during monocyte-to-macrophage differentiation: potential role of CD36 in foam cell formation. , 1996, Blood.
[46] J. Engelman,et al. Palmitoylation of Caveolin-1 at a Single Site (Cys-156) Controls Its Coupling to the c-Src Tyrosine Kinase , 2001, The Journal of Biological Chemistry.
[47] D. Steinberg,et al. Lewis A. Conner Memorial Lecture. Oxidative modification of LDL and atherogenesis. , 1997, Circulation.
[48] R. Silverstein,et al. Lysosomal Integral Membrane Protein II Binds Thrombospondin-1 , 1998, The Journal of Biological Chemistry.
[49] O. Volpert,et al. Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1 , 2000, Nature Medicine.
[50] H. Webster,et al. Molecular basis of sequestration in severe and uncomplicated Plasmodium falciparum malaria: differential adhesion of infected erythrocytes to CD36 and ICAM-1. , 1991, The Journal of infectious diseases.
[51] S. Hazen,et al. Myeloperoxidase-generated reactive nitrogen species convert LDL into an atherogenic form in vitro. , 1999, The Journal of clinical investigation.
[52] S. Hazen,et al. Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice. , 2000, The Journal of clinical investigation.